Health conditions
(Data source: WHO)
Epilepsy in Children
Interventions (Data source: WHO)
Other: assessment of perception and evaluation of physicians advisory skills per questionnaire
Inclusion/Exclusion Criteria
(Data source: WHO)
Inclusion Criteria:
- newly diagnosed epilepsy (according to International League Against Epilepsy (ILAE)
criteria):
- at least two unprovoked epileptic fits at intervals of at least 24 hours or
- one unprovoked epileptic fit and a recurrence risk of at least 60% or
- epilepsy syndrome
Exclusion Criteria:
- children with intensive care treatment as inpatients
- parents with insufficient German language capabilities
- parents and children with exposure to traumatic events in the past three months that
could probably lead to post traumatic distress (loss of a loved person, severe traffic
accident, raid, violence, sexual assault, war)
-
Further information on trial
Date trial registered
Jan 9, 2019
Incorporation of the first participant
Apr 30, 2019
Recruitment status
Recruiting
Academic title
(Data source: WHO)
Bad News- Diagnosis: Epilepsy in Childhood
Type of trial
(Data source: WHO)
Observational
Phase
(Data source: WHO)
Phase 2/Phase 3
Primary end point
(Data source: WHO)
perception of physicians advisory skills with respect to actual distress
Secundary end point
(Data source: WHO)
Pediatric Quality of Life Inventory (PedsQL 4.0);Child behaviour checklist (CBCL);Questionnaire on the assessment of stress and stress management in Childhood and Adolescence Revision (SSKJ 3-8 R);Change in Pediatric Quality of Life Inventory (Peds-QL);Change in Parenting Stress Index (PSI);Change in Stress Coping Style Questionnaire (SVF) 78/78-S;Change in Adult-Self-Report for Ages 18- 59 (ASR 18-59);Change in Stress and Coping Inventory (SCI);Change in National Comprehensive Cancer Network (NCCN) thermomete
Contact information
(Data source: WHO)
Please refer to primary and secondary sponsors
Trial results
(Data source: WHO)
Results summary
no information available yet
Link to the results in the primary register
no information available yet
Information on the availability of individual participant data
no information available yet
Trial sites
Countries
(Data source: WHO)
Switzerland
Contact for further information on the trial
Contact for general information
(Data source: WHO)
Peter Weber, Prof. Dr.;Peter Weber, Prof.Dr.
Universitäts-Kinderspital beider Basel UKBB
+41 61 704 19 08
peter.weber@ukbb.ch
Contact for scientific information
(Data source: WHO)
Peter Weber, Prof. Dr.;Peter Weber, Prof.Dr.
Universitäts-Kinderspital beider Basel UKBB
+41 61 704 19 08
peter.weber@ukbb.ch
Further trial identification numbers
Secondary ID (Data source: WHO)
2018-02397
ks18Weber
Back to overview
